2010 Annual Meeting

Session: Model Based Integrated Design of Pharmaceutical Drug Product and Process

This session would specifically focus on work where a modeling approache coupled with optimization techniques are used in some decision making during the design of a pharmaceutical drug product and its process. This is an area of great interest from a Quality by Design perspective; and the use of modeling technology is an important trend in our business.

Chair

Salvador Garcia-Munoz, Pfizer Global Research & Development

Co-Chair

Nick Sahinidis, Carnegie Mellon University

Presentations

12:30 PM

12:55 PM

Fani Boukouvala, Fernando J. Muzzio, Marianthi G. Ierapetritou

01:20 PM

Jon Hilden, Mark Schrad, Jessica T. Sloan, Jennifer Kuehne-Willmore, Timothy Kramer

01:45 PM

Ariel Muliadi, Carl R. Wassgren, James D. Litster

02:10 PM

Mark Schrad, Jon Hilden, Jessica T. Sloan, Jennifer Kuehne-Willmore

02:35 PM

Daniele Suzzi, Gregor Toschkoff, Daniel Machold, Johannes Khinast